Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology

Clin Cancer Res. 2006 Sep 15;12(18):5603. doi: 10.1158/1078-0432.CCR-06-0897.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Diagnosis, Differential
  • Endometrium / drug effects
  • Female
  • Humans
  • Postmenopause / drug effects*
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use*
  • Ultrasonography
  • Uterine Diseases / chemically induced*
  • Uterine Diseases / diagnosis
  • Uterine Diseases / diagnostic imaging

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen